Public Health

In part 3 of our interview, Jennifer Flynn, CPHRM, flips the script on potential harms in using social media and explores how pharmacists can use it to advance their career.

Jennifer Flynn, CPHRM, joins Drug Topics to discuss the nuances in social media use for pharmacists and the potential risks they can encounter.

Jennifer Flynn, CPHRM, vice president of health care risk management at the Healthcare Provider Service Organization, discusses pharmacists’ roles in patient privacy.

Kenric B. Ware, PharmD, MBA, AAHIVP, presents persistently common stigmas in HIV care and prevention from a recent NPhA webinar.

With OTC drug abuse on the rise, particularly among young people, researchers want to better understand ways to prevent it.

In an exploration of the National Retail Data Monitor, researchers determine how OTC sales contributed to disease surveillance.

John C. Goodman, PhD, senior fellow at the Independent Institute, discusses TrumpRx and its goals for patients’ OOP drug costs.

Morgan McSweeney, PhD, discusses America's public health decision-making, urging reforms to combat misinformation and safeguard scientific integrity in health agencies.

Jeffrey Bratberg, PharmD, BCPS, and Michelle Caetano, PharmD, BCACP, CVDOE, CDOE, BCPT, discuss the Pharmacy Bridge resource and pharmacists’ role in OUD management.

Conflicting federal health guidance creates confusion and erodes public trust, impacting patient safety and access to vital medical interventions.

Patient safety organizations began in the early 21st century to improve health care safety measures amongst various providers’ practices.

Catie Stimmel, PharmD, discusses the pharmacist’s role in ensuring PSOs operate at their intended capabilities.

Morgan McSweeney, PhD, discusses how social media highlights the most emotionally charged voices, often those offering anecdotes or outrage over careful analysis.

Catie Stimmel, PharmD, explores the confidentiality and non-punitive processes that are crucial in driving value toward patient safety organizations.

Catie Stimmel, PharmD, discusses what PSOs are and how they are protecting patients all across the US health care system.

Experts at the Milken Institute address better ways of adopting pharmacy services within the greater health care ecosystem.

A study reveals declining support for COVID-19 measures over time, highlighting the critical role of pharmacists in providing essential health education.

Study authors explore online purchasing habits for prescription-only and OTC medications.

Researchers explore highly engaged social media posts related to glucagon-like peptide-1 receptor agonists, attention deficit/hyperactivity disorder stimulants, and autoimmune biologics.

This collaboration is designed to bring resources addressing pharmacy shortages to the fingertips of the general public.

Living in West Virginia for over a decade, Mark Garofoli, PharmD, BCGP, CPE, CTTS, shares his experience as a practicing pharmacist amid the US opioid crisis.

Mark Garofoli, PharmD, BCGP, CPE, CTTS, shares his pain management expertise and discusses current developments in the US opioid epidemic.

Through diabetes education and initiatives focused on community health care, Clipper F. Young, PharmD, MPH, CDCES, BC-ADM, BCGP, is making a difference for patients and the pharmacy profession.

Pharmacists can help to address access issues, offer comprehensive medication counseling, and educate patients about disease management.

Using the PhotoVoice methodology, researchers conduct a study exploring Latinx adolescents’ preferences and the impacts of the COVID-19 pandemic and vaccine messaging.